Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 74497

4 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
June 17, 2016
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Teva North America

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

4 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 4

ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-0020-31 (Single Use Bag), NDC # 0703-0020-32 (5 Single Use Bags in One Carton).

D-1494-2016
Recall number
D-1494-2016
Initiated
June 17, 2016
Classification
Class II
Status
Terminated
Recalling firm
Teva North America
Quantity
1,299 bags

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations

Code information

All lots within Expiry. Lot # 4720915, 6790315, 6800315, 6810315, 6820315

Distribution pattern

Nationwide and Puerto Rico

drug · product 2 of 4

Linezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-9060-31- (Single Use Container), NDC# 0703-9060-33 (Box of 10 Singe Use Containers)

D-1495-2016
Recall number
D-1495-2016
Initiated
June 17, 2016
Classification
Class II
Status
Terminated
Recalling firm
Teva North America
Quantity
92,480 containers

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations

Code information

All Lots Within Expiry

Distribution pattern

Nationwide and Puerto Rico

drug · product 3 of 4

Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial, For Intravenous Use Only, Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-1179-01.

D-1496-2016
Recall number
D-1496-2016
Initiated
June 17, 2016
Classification
Class II
Status
Terminated
Recalling firm
Teva North America
Quantity
14,661 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations

Code information

All Lots Within Expiry Lot# 2710715, 2720715, 2730715, 3110715, 3120715

Distribution pattern

Nationwide and Puerto Rico

drug · product 4 of 4

Ondansetron Injection USP 40 mg/20 mL (2 mg/mL), Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454 NDC # 0703-7226-01 (20 mL- Multi-dose Vial), NDC # 0703-72263-03 (10 Multi-dose Vials per carton)

D-1497-2016
Recall number
D-1497-2016
Initiated
June 17, 2016
Classification
Class II
Status
Terminated
Recalling firm
Teva North America
Quantity
13,223 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
CGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

CGMP Deviations

Code information

All Lots Within Expiry Lot # 2930614, 2940614, 2950614

Distribution pattern

Nationwide and Puerto Rico